Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Other financing activities (2018 - 2024)

Historic Other financing activities for BioCorRx (BICX) over the last 9 years, with Q1 2024 value amounting to $2584.0.

  • BioCorRx's Other financing activities fell 9107.4% to $2584.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $2584.0, marking a year-over-year change of. This contributed to the annual value of $2584.0 for FY2024, which is N/A changed from last year.
  • Per BioCorRx's latest filing, its Other financing activities stood at $2584.0 for Q1 2024, which was down 9107.4% from -$28949.0 recorded in Q2 2023.
  • BioCorRx's Other financing activities' 5-year high stood at $28949.0 during Q1 2023, with a 5-year trough of -$28949.0 in Q2 2023.
  • For the 3-year period, BioCorRx's Other financing activities averaged around -$4416.5, with its median value being -$8833.0 (2022).
  • The largest annual percentage gain for BioCorRx's Other financing activities in the last 5 years was 9107.4% (2024), contrasted with its biggest fall of 9107.4% (2024).
  • BioCorRx's Other financing activities (Quarter) stood at -$20250.0 in 2022, then crashed by 42.96% to -$28949.0 in 2023, then surged by 108.93% to $2584.0 in 2024.
  • Its last three reported values are $2584.0 in Q1 2024, -$28949.0 for Q2 2023, and $28949.0 during Q1 2023.